Recent developments in immunotherapy of acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2017-07-25 / J Hematol Oncol 2017 07;10(1):142Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells
/in Acute Leukemia, Hyperthermia, International Publications /von 2017-04-28 / J. Therm. Biol. 2017 Jul;67:9-14Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2017-04-14 / Cancer 2017 Aug;123(16):3061-3072Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
/in Acute Leukemia, Dendritic Cells, International Publications /von 2016-12-07 / Sci Transl Med 2016 12;8(368):368ra171Induction of Immune Response after Allogeneic Wilms‘ Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse
/in Acute Leukemia, Dendritic Cells, International Publications /von 2016-09-12 / Biol. Blood Marrow Transplant. 2016 12;22(12):2149-2154Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies
/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International Publications /von 2016-06-09 / Expert Opin Biol Ther 2016 09;16(9):1113-23Long-term follow-up of patients with acute myelogenous leukemia receiving an autologous telomerase-based dendritic cell vaccine.
/in Acute Leukemia, Dendritic Cells, International Publications /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr 7007)Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma /von 2015-01-22 / Br. J. Haematol. 2015 May;169(3):356-67Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
/in Acute Leukemia, Dendritic Cells, International Publications, Multiple Myeloma /von 2014-01-01 / Hum Vaccin Immunother 2014;10(11):3125-31
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de